Vbi Vaccines Inc CS (VBIV)

$0.63 0.02 (3.11%)

14:12 EST VBIV Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jan 5, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers for Thursday that traders need to know about!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

VBIV Stock Is Shooting Higher on Big FDA Vaccine Approval News

More Articles

Volume:

Previous Close -

Market Cap 163.76M

PE Ratio -9.06

EPS -0.07

Volume (Avg. Vol.) 826,284

Day's Range $0.61 - $0.68

52-Week Range $0.36 - $1.86

Dividend & Yield N/A (N/A)

VBIV Stock Predictions, Articles, and Vbi Vaccines Inc CS News

From InvestorPlace
From the Web

7 Penny Stocks Waiting on the FDA for Rocket Fuel

By Thomas Niel, InvestorPlace Contributor Sep 9, 2021

News of regulatory approval or progress would really help to move the needle for these seven biotech penny stocks.

8 Biotech Penny Stocks for Investors to Watch

By Thomas Niel, InvestorPlace Contributor Mar 10, 2021

Low-priced biotechs have sold off recently, but there could still be potential in these picks. Here are eight penny stocks to consider.

8 Penny Stocks to Avoid in 2021

By Thomas Niel, InvestorPlace Contributor Jan 11, 2021

With risk-return not in your favor, steer clear of these 8 penny stocks, all of which could see big declines as the new year unfolds. Chesapeake Energy (OTCMKTS:CHKAQ) Genius Brands (NASDAQ:GNUS) Hertz Global Holdings (OTCMKTS:HTZGQ) Remark Holdings (NASDAQ:MARK) Ocugen (NASDAQ:OCGN) StoneMor (NYSE:STON) VBI Vaccines (NASDAQ:VBIV) XspresSpa (NASDAQ:XSPA)

7 Short-Term Stocks to Make a Quick Buck

By Josh Enomoto, InvestorPlace Contributor Oct 16, 2020

It wasn’t just toilet paper that was in demand when Covid-19 hit us as short-term stocks flew through the roof. But with a second wave upon us, this narrative looks very compelling.

While Risks Remain, VBI Vaccines Stock Is a Buy at Today’s Prices

By Thomas Niel, InvestorPlace Contributor Feb 5, 2020

Sci-B-Vac's success will make or break VBIV stock. But the shares' recent pullback may have created a great buying opportunity.

5 Stocks Under $5 With Colossal Growth Prospects

By Maya Sasson, Writer, TipRanks Jan 31, 2020

While some argue you get what you pay for, others say that stocks trading at low levels can represent compelling opportunities.

Is It Time to Go Long on VBIV Stock?

By Chris Markoch, InvestorPlace Contributor Jan 30, 2020

As a speculative pharmaceutical investment, VBIV stock is not for the faint of heart. However, the underlying business suggests some rationale for longer-term optimism.

VBI Vaccines News: VBIV Stock Skyrockets 17% on Clinical Trial Success

By William White, InvestorPlace Writer Jan 13, 2020

VBI Vaccines (VBIV) news for Monday about results from a recent clinical trial of a hepatitis B vaccine have VBI stock soaring.

5 Stocks to Buy Based on Insider Buying

By Mark Putrino, CMT Oct 8, 2019

These are five stocks to consider buying because of significant insider buying activity. Insiders only buy for one reason: to make money.

3 Pivotal Drug Trials to Watch for Explosive Potential

By Samuel Rae, InvestorPlace Contributor Jun 29, 2017

Here's a look at three biotech stocks that have at least one treatment prepped to enter pivotal clinical trials soon.

VBI Vaccines wins Health Canada approval for hepatitis B vaccine PreHevbrio (NASDAQ:VBIV)

From Seeking Alpha Dec 8, 2022

Health Canada has approved VBI Vaccines (VBIV) hepatitis B vaccine PreHevbrio.The approval is the fourth for the triple-antigen shot.

Stocks That Hit 52-Week Lows On Wednesday

From Benzinga May 25, 2022

On Wednesday, 215 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Tuesday

From Benzinga May 24, 2022

On Tuesday, 540 companies set new 52-week lows.

VBI Vaccines To Start Clinical Study Of Pan-Coronavirus Vaccine Candidate This Year

From Benzinga Apr 5, 2022

VBI Vaccines Inc (NASDAQ: VBIV) announced

Stocks That Hit 52-Week Lows On Tuesday

From Benzinga Feb 22, 2022

During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to...

Pan-COVID-19 Vaccine Could Be a Solution to End the Pandemic; Jefferies Taps 2 Stocks to Benefit

From TipRanks Jan 20, 2022

The coronavirus pandemic is still making headlines; it’s presenting us with a stubborn problem, one that won’t go away and resists the normal weapons that modern me...